Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement (Q35553375)
scientific article published on October 2004
Language:
(P31) (Q13442814)
(P50) (Q30112530)
(Q73304219)
(P304) 1218-1221
(P407) (Q1860)
(P433) 10
(P478) 63
(P577) Friday, October 1, 2004
(P921) (Q79460)
(Q187255)
(P1433) (Q4767876)
(P1476) "Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement" (language: en)
(P2093) Alessandri C
Bombardieri M
Papa N
Cinquini M
Magrini L
(P2860) (Q33626291)
(Q35073922)
(Q35552357)
(Q34963107)
(Q44176103)
(Q32133798)
(Q33925623)
(Q42631739)
(Q33896020)
(Q33885648)
(Q40914450)
(Q24628871)
(Q27860872)
(Q24678035)
(Q44412980)
(Q35111849)
(Q34964320)
(Q35551832)
(Q43618873)
(Q44791267)
(Q42689767)
(Q24564876)
(Q57751478)
(Q57789144)
(Q74364140)
(Q78025442)
(Q77061247)
(Q74402210)
(Q78309903)
(Q69785881)
other details
description scientific article published on October 2004

External Links